IBM Retirement Fund’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-2,840
Closed -$221K 521
2021
Q4
$221K Sell
2,840
-1,982
-41% -$175K 0.03% 517
2021
Q3
$460K Hold
4,822
0.04% 439
2021
Q2
$599K Sell
4,822
-251
-5% -$30K 0.05% 361
2021
Q1
$669K Sell
5,073
-438
-8% -$60K 0.05% 351
2020
Q4
$730K Buy
5,511
+680
+14% +$82.2K 0.05% 327
2020
Q3
$493K Buy
4,831
+1,357
+39% +$117K 0.04% 365
2020
Q2
$302K Buy
+3,474
New +$278K 0.04% 392
2019
Q3
Sell
-1,984
Closed -$234K 420
2019
Q2
$234K Buy
+1,984
New +$200K 0.04% 374

Other funds holding EXAS

IBM Retirement Fund's EXAS Position: Q1 2022 in Review

IBM Retirement Fund sold out of Exact Sciences (EXAS) in Q1 2022, closing a stake of 2,840 shares — an estimated $221K sold.

IBM Retirement Fund first reported a position in EXAS in Q2 2019 and held it in 8 quarters. The position peaked at $730K in Q4 2020. 559 funds tracked by Wall St. Rank hold EXAS as of Q1 2022.

  • IBM Retirement Fund reported no remaining Exact Sciences position as of Q1 2022 after selling out during the quarter.
  • IBM Retirement Fund sold 2,840 Exact Sciences shares in Q1 2022, an estimated $221K.
  • IBM Retirement Fund first reported a position in Exact Sciences in Q2 2019 and held it in 8 quarters.
  • IBM Retirement Fund's Exact Sciences position peaked at $730K in Q4 2020.
  • 559 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2022.

Based on IBM Retirement Fund's 13F filing for Q1 2022, filed 14 Apr 2022.